Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Ikena Oncology, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues  15.631.09.224.9
            Revenue growth  -49.6%237.0%-63.1% 
Cost of goods sold  0.00.00.032.2
Gross profit  15.631.09.2-7.3
            Gross margin  100.0%100.0%100.0%-29.3%
Selling, general and administrative   [+]22.218.08.97.3
Research and development  64.347.144.8 
Other operating expenses     3.9
EBITDA   [+]-70.2-33.6-44.2-18.2
            EBITDA margin  -449.2%-108.4%-481.0%-73.2%
Depreciation and amortization  0.80.50.30.2
EBIT   [+]-70.9-34.1-44.5-18.5
            EBIT margin  -454.0%-110.2%-484.2%-74.2%
Interest income  2.10.0  
Other income (expense), net   [+]0.0 0.318.5
Pre-tax income  -68.8-34.1-44.30.0
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0% 
Net income  -68.8-34.1-44.30.0
            Net margin  -440.3%-110.1%-481.4%0.0%
   
Basic EPS   [+]($1.90)($1.22)($16.00)$0.00
Diluted EPS   [+]($1.90)($1.22)($16.00)$0.00
   
Shares outstanding (basic)   [+]36.228.02.82,648.3
Shares outstanding (diluted)   [+]36.228.02.82,648.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy